![Mats-Olof Wallin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mats-Olof Wallin
Director of Finance/CFO at
OxThera AB
Profile
Mats-Olof Wallin is currently the Chief Financial Officer & Deputy CEO at OxThera AB since 2020.
Prior to this, he worked as the CFO & Director-Investor Relations at Biotage AB from 2003 to 2012, the Chief Financial Officer at Karo Healthcare AB from 2018 to 2019, and the Chief Financial Officer & Senior Vice President at Swedish Orphan Biovitrum AB from 2013 to 2018.
He completed his undergraduate degree from the University of Uppsala.
Mats-Olof Wallin active positions
| Companies | Position | Start |
|---|---|---|
OxThera AB
 OxThera AB Medical/Nursing ServicesHealth Services Develops novel treatments for hyperoxaluria leading to kidney damage and potential organ failure | Director of Finance/CFO | 01/01/2020 |
Former positions of Mats-Olof Wallin
| Companies | Position | End |
|---|---|---|
| KARO PHARMA AB (PUBL) | Director of Finance/CFO | 01/10/2019 |
| SWEDISH ORPHAN BIOVITRUM AB | Director of Finance/CFO | 20/07/2018 |
| BIOTAGE AB | Director of Finance/CFO | 01/01/2012 |
Training of Mats-Olof Wallin
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
67
1st degree connections
5
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Karo Healthcare AB
 Karo Healthcare AB Household/Personal CareConsumer Non-Durables Manufactures skincare products, cosmetics, supplements and digestive pharmaceuticals | Consumer Non-Durables |
Biotage AB
 Biotage AB Medical SpecialtiesHealth Technology Develops workflow solutions, instruments and consumables used in drug discovery & pharmaceutical development | Health Technology |
University of Uppsala
 University of Uppsala Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
OxThera AB
OxThera AB Medical/Nursing ServicesHealth Services Develops novel treatments for hyperoxaluria leading to kidney damage and potential organ failure | Health Services |
Swedish Orphan Biovitrum AB
 Swedish Orphan Biovitrum AB Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceuticals and orphan drugs in the areas of hematology, immunology and specialty care | Health Technology |
- Stock Market
- Insiders
- Mats-Olof Wallin
